Evaluation of a novel antigen-enhanced, anti-idiotypic antibody vaccine strategy

Ended Project Grant Awarded Last action

Award ID
R21AI143505
Recipient
Awarding agency
Obligated
$454,562

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
Ames, IA 50014, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $40,449
Amendment $29,113
Amendment $210,000
Original award $175,000

Quick answers

Who received award R21AI143505?

R21AI143505 was awarded to Neovaxsyn Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 18, 2018.

How much is award R21AI143505 worth?

$454,562 has been obligated on R21AI143505.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award